Breakthrough Therapy Restores Mobility in Kids with Severe Fibrous Dysplasia
Children with severe fibrous dysplasia—a rare bone disorder causing painful skeletal deformities—have shown clinically meaningful mobility improvements in a Phase II trial of a targeted kinase inhibitor, published this week ... Read More